State University of New York, Syracuse
Also known as: Ajeet Gajra | State University of New York - Upstate Medical University | State University of New York, Upstate Medical University - Department of Psychiatry | State University of New York, Upstate Medical University (SUNY-UMU) | SUNY Upstate | SUNY Upstate Medical University | SUNY Upstate Medical University, Department of Psychiatry | SUNY Upstate Medical University, Psychiatry Department | SUNY Upstate Medical University, Psychiatry Dept. | SUNY Upstate Medical University - Syracuse, NY | SUNY Upstate Medical Unversity | SUNY Upstate UH | Upstate Medical Univeristy Syracuse | Upstate Medical University, State University of New York (SUNY) | Upstate Medical University, SUNY
Highest phase reached
Phase 4
First clinical trial
Nov 1, 1996Last known activity
Oct 31, 2025
Timeline
1830s
- Jan 1, 1834
State University of New York, Syracuse— Founded
Drugs by trial phase (80 distinct, 66 trials)
Phase 4 (17 own, 0 via acquisition)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (20 own, 0 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Other trials (11 own, 0 via acquisition)
Indications
Studied for
- Alcoholism
- Alcohol-Related Disorders
- Amyotrophic Lateral Sclerosis
- Anxiety Disorders
- Bipolar Disorder
- Body Weight
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Dengue
- Depression
- Depressive Disorder
- DiGeorge Syndrome
- Disease
- Fatigue
- Fibromyalgia
- Headache
- Head and Neck Neoplasms
- Heart Failure
- Hematuria
- Hepatitis
- Hepatitis A
- Hepatitis C
- Kidney Diseases
- Kidney Failure, Chronic
- Liver Diseases
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Mental Disorders
- Migraine Disorders
- Motor Neuron Disease
- Mucopolysaccharidoses
- Mucopolysaccharidosis II
- Multiple Myeloma
- Myofascial Pain Syndromes
- Neoplasms, Plasma Cell
- Ovarian Neoplasms
- Phobia, Social
- Postoperative Pain
- Psychotic Disorders
- Rabies
- Schizophrenia
- Sclerosis
- Sleep Initiation and Maintenance Disorders
- Small Cell Lung Carcinoma
- Stress Disorders, Post-Traumatic
- Substance-Related Disorders
- Syndrome
- Tobacco Use Disorder
- Urinary Bladder Neoplasms
- Vomiting
- Weight Gain
Recent trials (50)
- NCT07189897Sponsor investigatorPhase 4Oct 31, 2025
- NCT07189897Lead sponsorPhase 4Oct 31, 2025
- NCT07189897CollaboratorPhase 4Oct 31, 2025
- NCT06611111OfficialEarly Phase 1Nov 30, 2024
- NCT06611111Lead sponsorEarly Phase 1Nov 30, 2024
- NCT06217302CollaboratorPhase 3Oct 15, 2024
- NCT06370442OfficialPhase 3Jun 1, 2024
- NCT06370442Sponsor investigatorPhase 3Jun 1, 2024
- NCT06370442Lead sponsorPhase 3Jun 1, 2024
- NCT06150287Lead sponsorEarly Phase 1Feb 29, 2024
- NCT06150287Overall official - principal investigatorEarly Phase 1Feb 29, 2024
- NCT06238778OfficialPhase 2Jan 23, 2024
- NCT05967455Overall official - principal investigatorPhase 1Oct 30, 2023
- NCT05967455Lead sponsorPhase 1Oct 30, 2023
- NCT06219967Lead sponsorPhase 4Jan 4, 2023
Details
- Founded
- Syracuse, NY, US Jan 1, 1834
- Last known activity
- Oct 31, 2025